Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

3(50.0%)

6Total

N/A(3)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07339371Not Yet Recruiting

Comprehensive Care of Sleep Disordered Breathing

Role: collaborator

NCT06537167Not ApplicableNot Yet Recruiting

Transcutaneous Electrical Acupoint Stimulation on Blood Pressure

Role: collaborator

NCT06780865Not ApplicableNot Yet Recruiting

Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension

Role: lead

NCT04035824Phase 4Completed

Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study

Role: lead

NCT04137549Recruiting

Registry Study on "Control Nocturnal Hypertension to Reach the Target "

Role: lead

NCT05858944Not ApplicableRecruiting

Home Blood Pressure Intervention in the Community Trial

Role: lead

NCT02156024Phase 4Unknown

The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension

Role: lead

NCT01922687Phase 4Unknown

Amlodipine Plus/Minus Atorvastatin for Protection of Arteries

Role: lead

All 8 trials loaded